(a)
(b)
Figure 4: (a) Sensitivity analysis of urolithiasis risk associated with the CaSR A986S polymorphism under the dominant model. (b) Sensitivity analysis of urolithiasis risk associated with the CaSR R990G polymorphism under the dominant model.